Navigation Links
Epilepsy Drugs Market in Europe - Market Analysis 2015-2019 - Reportlinker Review
Date:10/12/2015

NEW YORK, Oct. 12, 2015 /PRNewswire/ -- About epilepsy

Epilepsy refers to a spectrum of brain disorders manifested by benign to severe, disabling, and life-threatening symptoms. It is caused by factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and trauma during birth. When the underlying cause of the disease is unidentified, as is witnessed in the majority of cases, it is known as idiopathic epilepsy. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures.

Technavio's analysts forecast the epilepsy drugs market in Europe to grow at a CAGR of 3.22% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the epilepsy drugs market in Europe for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of epilepsy.

Technavio's report, Epilepsy Drugs Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as market segmentation and pipeline landscape. The report includes a discussion of the key vendors operating in this market.

Key vendors

• Eisai

• GlaxoSmithKline

• Pfizer

• UCB

Other prominent vendors

• AbbVie• Janssen Pharmaceuticals• Lundbeck• Meda• Novartis• Roche• Shire• Sunovion Pharmaceuticals• Supernus Pharmaceuticals• Upsher-Smith• Valeant Pharmaceuticals

Market driver

• Unmet medical needs

• For a full, detailed list, view our report

Market challenge

• Patent expiry• For a full, detailed list, view our report

Market trend

• Reformulation of marketed drugs

• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2019 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key vendors?• What are the strengths and weaknesses of the key vendors?

Read the full report: http://www.reportlinker.com/p03312084-summary/view-report.html

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker reviews, finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 


'/>"/>
SOURCE Reportlinker
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. PhRMA and Epilepsy Foundation Report More Than 400 Medicines in Development to Treat Neurological Disorders
2. Memorial Hermann Successfully Completes Systems First NeuroPace RNS System Procedure for Epilepsy Patient
3. Epilepsy Drug May Preserve Eyesight for People with MS
4. Medical Marijuana Liquid Extract May Bring Hope for Children with Severe Epilepsy
5. Eisai Presents New Data on Perampanel and Rufinamide at the 68th Annual American Epilepsy Society Meeting
6. UCB, Georgia Institute of Technology Partner to Harness the Power of Predictive Analytics in Epilepsy Care
7. UCB reinforces its leadership in epilepsy at the 2014 Annual Meeting of the American Epilepsy Society (AES)
8. Northwest Epilepsy Conferences to Highlight Marijuana Treatments
9. PuraMed BioScience Nears Completion of a Hemp-Derived-Cannabinoid-Based Non-Prescription Medication for Treatment of Epilepsy Symptoms
10. Landmark National Survey Seeks To Shed Light On Impact Of Rare Seizure Pattern In Epilepsy
11. Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2018)... ... , ... Dr. Rajdeep S. Randhawa of Innovative Dentistry has been reviewed ... and Restorative Dentistry’ which includes an exclusive group of 6 Top Dentists out ... dentist website. Dr. Randhawa has been practicing dentistry since 1988 and specializes in ...
(Date:10/18/2018)... CLEARWATER, Fla. (PRWEB) , ... October 18, 2018 ... ... platform dedicated to simplifying the process of buying insurance, announced today the launch ... EZ-App was developed by Ensurem as part of its mission to streamline the ...
(Date:10/17/2018)... ... 17, 2018 , ... Dr. Dan Holtzclaw, Chief Clinical Officer ... use of placental based growth factors for the treatment of nerve injuries related ... DIA Dental Implant Center locations in Austin and San Antonio, we occasionally see ...
Breaking Medicine Technology:
(Date:10/13/2018)... ... 2018 , ... Convoy of Hope’s Disaster Services Team is currently in Marianna, ... set up to serve hurricane survivors with water, food, baby products, hygiene kits, flood ... additional truckloads of supplies are in motion to Florida. , Convoy’s walk-up ...
(Date:10/13/2018)... , ... October 13, 2018 , ... ... on Sports, Fitness & Nutrition, has announced LaRhonda Burley as its new Vice ... congressionally chartered in 2010 to support and strengthen the mission of the President's ...
(Date:10/11/2018)... ... October 11, 2018 , ... The Danisco Foundation today has ... their fields recognized by DuPont Nutrition & Health for scientific excellence and a ... of food, nutrition and health. , This year’s medalists are: , ? DuPont ...
(Date:10/11/2018)... ... October 11, 2018 , ... Four weeks before the ... warns former U.S. Department of Homeland Security deputy assistant secretary Paul Rosenzweig in ... Can Stop it. , Pointing to the ability of Russian hackers to gain ...
(Date:10/7/2018)... ... 07, 2018 , ... Guruji Mahendra Trivedi is an innovative ... practical and spiritual levels. Founder of the Trivedi Effect®, Guruji Mahendra Trivedi will ... by Navratri, is a mystical time when Divine Energy is at its peak ...
Breaking Medicine News(10 mins):